Evidence map›Paper›PMID 30645731›Full record

ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2019

Comparative proteomic analyses of Hyphozyma roseonigra ATCC 20624 in response to sclareol.

Xiuwen Wang, Xiaohua Zhang, Qingshou Yao, Dongliang Hua, Jiayang Qin

Abstract readComparative Study
In one paragraph

Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Efforts toward Ambergris Biosynthesis.Chem & bio engineering · 2024
    Review
  3. The bioactivities of sclareol: A mini review.Frontiers in pharmacology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiuwen WangCollege of Pharmacy, Binzhou Medical University, Yantai, 264003, People's Republic of China.
Xiaohua ZhangCollege of Pharmacy, Binzhou Medical University, Yantai, 264003, People's Republic of China.
Qingshou YaoCollege of Pharmacy, Binzhou Medical University, Yantai, 264003, People's Republic of China.
Dongliang HuaKey Laboratory for Biomass Gasification Technology of Shandong Province, Energy Research Institute of Shandong Academy of Sciences, Jinan, China.
Jiayang QinCollege of Pharmacy, Binzhou Medical University, Yantai, 264003, People's Republic of China. qinjysdu@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sclareol is an important intermediate for ambroxide synthesis industries. Hyphozyma roseonigra ATCC 20624 was the only reported strain capable of degrading sclareol to the main product of sclareol glycol, which is the precursor of ambroxide. To date, knowledge is lacking about the effects of sclareol on cells and the proteins involved in sclareol metabolism. Comparative proteomic analyses were conducted on the strain H. roseonigra ATCC 20624 by using sclareol or glucose as the sole carbon source. A total of 79 upregulated protein spots with a > 2.0-fold difference in abundance on 2-D gels under sclareol stress conditions were collected for further identification. Seventy spots were successfully identified and finally integrated into 30 proteins. The upregulated proteins under sclareol stress are involved in carbon metabolism and nitrogen metabolism, and replication, transcription, and translation processes. Eighteen upregulated spots were identified as aldehyde dehydrogenases, which indicating that aldehyde dehydrogenases might play an important role in sclareol metabolism. Overall, this study may lay the fundamentals for further cell engineering to improve sclareol glycol production.

Indexed as

AscomycotaCarbonDiterpenesFungal ProteinsGlucoseProteomicsCarbonDiterpenesFungal ProteinsGlucosesclareolAmbroxideComparative proteomicHyphozyma roseonigraSclareolSclareol glycol

Identifiers

PMID30645731
PMCPMC6863283

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.